100% of Net Proceeds fund Research

Every single net penny you give... (no overhead, no administrative fees)
Goes directly to clinical trials and research
Giving our children a “Chance for Life”

Thank you for your interest in giving all children a Chance for Life. We are proud to fund research that drives new, innovative treatments for Pediatric Cancers especially in the area of pediatric neuro-oncology. The 2021 Chance for Life LOI process will begin accepting applications on September 28 for an LOI submission period between September 28 and December 31, 2020. .

Funding is available on a project basis for project requests up to $150,000. .

Please review the following funding notes and complete the below LOI questions to be included in communications regarding this application process..


Key Funding Notes:
  1. Focused, outcome oriented and innovative pediatric cancer research initiatives will be prioritized.
  2. Preference will be given to projects focused in pediatric neuro-oncology.
  3. Funding will be allocated to research activities taking place in the United States of America.
  4. Chance for Life welcomes the opportunity to be the sole source of funding.
  5. CFL’s evaluation process of research initiatives encourages collaborative, multi-disciplinary, multi-institutional efforts to achieve insight and innovation in the following areas:
    1. The basis of tumor initiation and progression,
    2. Novel therapeutic approaches
    3. Development of novel biomarkers or methodologies to predict disease progression, to enhance efforts in primary and secondary prevention and intervention
    4. Novel models that would enhance pre-clinical research,
    5. Development of more effective, less-invasive and/or less toxic treatments to improve long-term health and quality of life.


LOI Questions:

words. Please limit to 500 words or less.
(Download NIH standard biosketch format to complete)

Please click here to complete a Brand Licensing Pre-Approval Agreement. Completing this agreement is a requirement for funding approval.

Get our updates by email

We'll never share your email address and you can opt out at any time, we promise.